DNMT1 and neoplasm: Measurement of dissected tumor weights showed that intratumoral injection with AAV-pCD4-DNMT1 significantly reduced tumor mass, while intratumoral injection with AAV-pCD4-shDNMT1 significantly increased tumor mass, by representative images (Figure 4C), and by quantification (Figure 4D).